Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)
Hypertrophic Obstructive Cardiomyopathy
About this trial
This is an interventional treatment trial for Hypertrophic Obstructive Cardiomyopathy focused on measuring hypertrophic cardiomyopathy, mitral valve, SAM syndrome
Eligibility Criteria
Inclusion Criteria:
- Able to sign Informed Consent and Release of Medical Information forms
- Age ≥ 18 years
- obstructive hypertrophic cardiomyopathy
- mediated mitral insufficiency by SAM syndrome
- II-IV (NYHA),
- average systolic pressure gradient greater than 50 mm Hg. Art. at rest;
- basal or medium ventricular obstruction
Exclusion Criteria:
- Related defect of the aortic valve;
- Organic mitral valve disease (dysplasia, rheumatic fever, infective endocarditis);
- Surgically significant coronary artery lesions;
- Patients requiring implantation of a cardioverter-defibrillator
Sites / Locations
- Novosibirsk State Research Institute of Circulation PathologyRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
myectomy by Morrow
extended myectomy
Procedure: myectomy by Morrow. Will be included in a group of 30 patients with obstructive hypertrophic cardiomyopathy and mitral insufficiency. In the case of conservation SAM syndrome and mediated mitral insufficiency, the result will be read as unsatisfactory. Patients will perform advanced myoectomy. All patients who need to be supplemented by the operation extension myoectomy subsequently run out in the second group. When it is impossible to eliminate mediated mitral regurgitation without mitral valve replacement, patients performed myoectomy and mitral valve replacement. The result in this case is read as completely unsatisfactory. Upon reaching 15% replacement mitral valve study terminated. Evaluation results will be made myoectomy as TEE and direct tensiometer.
Procedure: extended myectomy. Will be included in a group of 30 patients with obstructive hypertrophic cardiomyopathy and mitral insufficiency. Intraoperatively for all patients will be executed TEE to calculate the volume of excision. All patients will be performed extended myoectomy which supplemented resection and release of the papillary muscles. In case of unsatisfactory MV repair will reconnect the device artificial circulation and mitral valve replacement. The result in this case will become engrossed in reading as completely unsatisfactory. At achievement of 15% prosthetics of the mitralny valve research stops. Evaluation results will be made myoectomy as TEE and direct tensiometer .